Fresh analysis reveals that individuals who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on shed pounds far faster than those who end conventional diet and exercise plans.
Research printed in a prominent medical journal points out that while overweight individuals frequently drop about a fifth of their total mass while on the medication, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using such medications must be cognizant of the risk of fast weight regain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain means a reversion to original mass in about a year and a half.
Comparing Therapies
The study, which looked at dozens of trials involving thousands of patients, compared the effects of the injectable medications with other pills.
The team point out that individuals who shed pounds through diet and exercise usually experience a more gradual creep back—approximately 0.1 kg a month—post-intervention.
Explaining the Fast Regain
Nutrition scientists propose the way of the jabs accounts for the accelerated regain.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Sustained high doses of the hormone concentrations far above than normal could lead to the body to produce less of its own natural hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating far more likely."
An Ongoing Condition?
The NHS suggest the jabs for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Many experts say that, given the significant potential of relapse, the therapy should be considered life-long.
This view is supported by pharmaceutical companies, who state that the results "underscore the chronic character of excess weight," similar to managing diseases like diabetes.
User Accounts
Individuals who have stopped the jabs report a powerful return of appetite.
"I experienced something that goes on and I was suddenly extremely hungry," recalled one woman.
This challenge is worsened if individuals have not established lasting lifestyle or habit changes during therapy.
Growing Interest
Survey data show that millions of adults in the UK have used these injections in the past year, with desire remaining high.
- Use is higher among women compared to males.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the medications through private healthcare rather than the NHS.
Finally, researchers emphasize that while these medications are effective agents for shedding pounds, they are not a magic fix and lasting health benefits likely depends on integrated lifestyle support.